MANFREDI, Andreina Teresa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.988
EU - Europa 12.612
AS - Asia 6.886
SA - Sud America 1.097
AF - Africa 183
OC - Oceania 90
Continente sconosciuto - Info sul continente non disponibili 17
Totale 38.873
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.620
IT - Italia 6.522
GB - Regno Unito 2.357
CN - Cina 2.116
SG - Singapore 2.066
SE - Svezia 972
HK - Hong Kong 955
BR - Brasile 842
DE - Germania 567
VN - Vietnam 386
RU - Federazione Russa 365
FR - Francia 361
TR - Turchia 356
UA - Ucraina 353
FI - Finlandia 293
JP - Giappone 193
ID - Indonesia 177
NL - Olanda 176
CA - Canada 165
IE - Irlanda 160
KR - Corea 158
BG - Bulgaria 157
MX - Messico 156
IN - India 153
AR - Argentina 112
AU - Australia 83
PL - Polonia 63
ZA - Sudafrica 60
PK - Pakistan 48
TN - Tunisia 44
LT - Lituania 37
EC - Ecuador 35
ES - Italia 34
MY - Malesia 34
BD - Bangladesh 33
CH - Svizzera 33
IR - Iran 31
IQ - Iraq 30
BE - Belgio 29
CL - Cile 28
CO - Colombia 24
PE - Perù 24
AT - Austria 23
EG - Egitto 23
RO - Romania 21
SA - Arabia Saudita 21
AE - Emirati Arabi Uniti 18
BZ - Belize 18
PH - Filippine 17
EU - Europa 16
MA - Marocco 16
HU - Ungheria 15
JO - Giordania 15
VE - Venezuela 14
KE - Kenya 13
PT - Portogallo 13
TH - Thailandia 13
TW - Taiwan 12
DZ - Algeria 10
IL - Israele 9
PY - Paraguay 9
UZ - Uzbekistan 9
DK - Danimarca 8
NZ - Nuova Zelanda 7
RS - Serbia 7
AL - Albania 6
DO - Repubblica Dominicana 6
LU - Lussemburgo 6
NP - Nepal 6
TT - Trinidad e Tobago 6
AZ - Azerbaigian 5
BO - Bolivia 5
CZ - Repubblica Ceca 5
HR - Croazia 5
NO - Norvegia 5
GR - Grecia 4
KG - Kirghizistan 4
MD - Moldavia 4
OM - Oman 4
UY - Uruguay 4
ET - Etiopia 3
HN - Honduras 3
KW - Kuwait 3
LB - Libano 3
LV - Lettonia 3
PA - Panama 3
BA - Bosnia-Erzegovina 2
CR - Costa Rica 2
GH - Ghana 2
GT - Guatemala 2
JM - Giamaica 2
KZ - Kazakistan 2
MU - Mauritius 2
NI - Nicaragua 2
PR - Porto Rico 2
PS - Palestinian Territory 2
QA - Qatar 2
SI - Slovenia 2
SN - Senegal 2
UG - Uganda 2
Totale 38.856
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.936
Fairfield 1.722
Southend 1.515
Singapore 1.435
Ashburn 1.321
Woodbridge 941
Hong Kong 931
Chandler 917
Houston 751
Wilmington 635
Chicago 627
Hefei 619
Seattle 586
Jacksonville 564
Ann Arbor 531
Cambridge 530
Nyköping 513
Milan 464
London 443
Los Angeles 441
Rome 435
Dearborn 387
Beijing 339
Salt Lake City 253
Modena 236
New York 224
Helsinki 181
Izmir 181
San Diego 181
The Dalles 152
Sofia 151
Princeton 147
Ho Chi Minh City 132
Redwood City 132
Jakarta 131
Seoul 128
Dallas 126
Dublin 125
Council Bluffs 124
Tampa 123
Eugene 113
Florence 112
Elk Grove Village 110
Shanghai 110
Bologna 109
Naples 102
Bari 99
Moscow 97
Palermo 96
Buffalo 94
Hanoi 88
São Paulo 86
Tokyo 78
Bremen 77
Catania 77
Falls Church 71
Frankfurt am Main 69
Genoa 64
Munich 55
Sterling 55
Verona 55
Turin 53
Lancaster 51
Mexico City 51
Boardman 50
Columbus 50
Padova 50
Des Moines 48
Perth 47
Miami 42
Phoenix 41
San Jose 41
Guangzhou 40
Cagliari 39
Toronto 38
Dulles 32
Atlanta 31
Parma 31
Redondo Beach 31
Dong Ket 30
Salerno 30
Ankara 29
Brooklyn 29
Messina 29
Montreal 29
Ottawa 29
San Francisco 29
Warsaw 29
Chennai 28
Denver 28
Manchester 28
Buenos Aires 27
Detroit 27
Kansas City 27
Kent 27
Brescia 26
Johannesburg 26
Norwalk 26
Mumbai 24
Pisa 24
Totale 24.474
Salva come PNG Salva come JPEG
Nome #
INTERSTIZIOPATIA POLMONARE NON CLASSIFICABILE O SECONDARIA A CONNETTIVITE INDIFFERENZIATA. IMPORTANZA E DIFFICOLTÀ DI UNA DIAGNOSI DIFFERENZIALE. 3.701
Epidemiology and management of interstitial lung disease in ANCA-associated vasculitis 1.223
TIPIZZAZIONE CLINICA DELLA SINDROME ANTISINTETASICA: CONFRONTO TRA PAZIENTI ANTI JO-1 POSITIVI E NEGATIVI 1.185
ALTERAZIONI CAPILLAROSCOPICHE IN CORSO DI DERMATOMIOSITE E SCLEROSI SISTEMICA; VERSO L’INDIVIDUAZIONE DI PATTERN SPECIFICI 861
La capillaroscopia in reumatologia. Lesioni elementari e metodi di scoring 501
Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients. 402
Oxycodone in the Long-Term Treatment of Chronic Pain Related to Scleroderma Skin Ulcers. 395
Bronchoalveolar lavage and response to cyclophosphamide in scleroderma alveolitis. 385
Evoluzione dello CSURI (Capillaroscopic Skin Ulcer Risk Index) in pazienti affetti da sclerosi sistemica in terapia con antiendotelina-1 e prostanoidi 378
Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: The InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device) 358
Analysis of pulmonary sounds for the diagnosis of interstitial lung diseases secondary to rheumatoid arthritis 354
Systemic sclerosis and cryoglobulinemia: our experience with overlapping syndrome of scleroderma and severe cryoglobulinemic vasculitis and review of the literature. 351
D-penicillamine in the treatment of eosinophilic fasciitis: case reports and review of the literature. 348
Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis 345
Effect of treatment with iloprost with or without bosentan on nailfold videocapillaroscopic alterations in patients with systemic sclerosis 344
Nailfold Videocapillaroscopy Alterations in Dermatomyositis and Systemic Sclerosis: Toward Identification of a Specific Pattern 339
Radiological thymus alterations in systemic sclerosis: our experience and a review of the literature. 332
Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients' population and review of the literature 327
Recommendations for the management of pulmonary fungal infections in patients with rheumatoid arthritis 324
Therapeutic options after treatment failure in rheumatoid arthritis or spondyloarthritides 321
Scleroderma digital ulcers complicated by infection with fecal pathogens. 317
CXCL10 (α) and CCL2 (β) chemokines in systemic sclerosis - A longitudinal study 317
Radiologic classification of usual interstitial pneumonia in rheumatoid arthritis-related interstitial lung disease: correlations with clinical, serological and demographic features of disease 313
Circulating CXCL11 and CXCL10 are increased in hepatitis C-associated cryoglobulinemia in the presence of autoimmune thyroiditis. 307
Current treatment of hepatitis C-associated rheumatic diseases. 306
Combination Therapy with Nintedanib and Sarilumab for the Management of Rheumatoid Arthritis Related Interstitial Lung Disease 304
Efficacia di terapia con immunoassorbimento con proteina A dello stafilococco e talidomide in un caso di dermatomiosite refrattaria. 300
NEW PERSPECTIVES IN DIAGNOSIS OF INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. VALIDATION STUDY OF AN ELECTRONIC STETHOSCOPE AND AD HOC SOFTWARE FOR DETECTION OF PULMONARY CRACKLES 299
Aortic pulse wave velocity measurement in systemic sclerosis patients. 298
Carotidynia Possibly due to Localized Vasculitis in a Patient with Latent Mycobacterium tuberculosis Infection. 294
Staphylococcus protein A-based extracorporeal immunoadsorption and thalidomide in the treatment of skin manifestation of dermatomyositis: a case report. 288
Cardiac Involvement in Systemic Vasculitis 288
Gynaecological Screening for Cervical and Vulvar Malignancies in a Cohort of Systemic Sclerosis Patients: Our Experience and Review of the Literature 279
Recombinant human erythropoietin stimulates vasculogenesis and wound healing in a patient with systemic sclerosis complicated by severe skin ulcers. 279
Platelet gel in the treatment of severe scleroderma skin ulcers. 278
Serum 25-OH vitamin D levels in systemic sclerosis: analysis of 140 patients and review of the literature 276
Cryoglobulinemic vasculitis and skin ulcers. Our therapeutic strategy and review of the literature 271
Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature 271
Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline 261
High circulating chemokines (C-X-C motif) ligand 9, and (C-X-C motif) ligand 11, in hepatitis C-associated cryoglobulinemia. 259
Modulatory effects of peroxisome proliferator-activated receptor-γ on CXCR3 chemokines 257
Antiendothelial cell antibodies induce apoptosis of bone marrow endothelial progenitors in systemic sclerosis 254
Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: Clinical and prognostic implications 253
Nailfold capillaroscopic changes in dermatomyositis and polymyositis 252
Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature. 252
Cardiovascular risk and prostanoids in systemic sclerosis 250
Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement 248
Prediction risk chart for scleroderma digital ulcers: A composite predictive model based on capillaroscopic, demographic and clinico-serological parameters 245
Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: Our interdisciplinary rheumatology-pneumology experience, and review of the literature 244
Capillaroscopic Skin Ulcers Risk Index (CSURI) calculated with different videocapillaroscopy devices: how its predictive values change 238
Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study 238
HRCT Patterns Of Usual Interstitial Pneumonia In Rheumatoid Lung 236
AB1157 VALIDATION OF VECTOR (VELCRO CRACKLES DETECTOR) FOR THE DIAGNOSIS OF INTERSTITIAL LUNG DISEASE IN PATIENTS WITH CONNECTIVE TISSUE DISEASES 236
Timing of onset affects arthritis presentation pattern in antisyntethase syndrome 233
CORRELATION OF A QUANTITATIVE VIDEOCAPILLAROSCOPIC SCORE WITH THE DEVELOPMENT OF DIGITAL SKIN ULCERS IN SCLERODERMA PATIENTS 231
Correlation of a quantitative videocapillaroscopic score with the development of digital skin ulcers in scleroderma patients 230
COST ANALYSIS RELATED TO SUBCUTANEOUS IMMUNOGLOBULINS IN PATIENTS WITH INFLAMMATORY MYOPATHIES AND IMMUNE-MEDIATED CHRONIC NEUROPATHIES. RESULTS OF AN OPEN LABEL STUDY 226
Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicenter retrospective study 226
Validation study of predictive value of capillaroscopic skin ulcer risk index (CSURI) in scleroderma patients treated with bosentan 225
Interstitial pneumonia with autoimmune features: A single center prospective follow-up study 222
Acute exacerbation of interstitial lung disease associated with rheumatic disease 217
Antifibrotic drugs in connective tissue disease-related interstitial lung disease (CTD-ILD): from mechanistic insights to therapeutic applications 216
Predictive role of capillaroscopic skin ulcer risk index in systematic sclerosis: a multicentre validation study 215
CAPILLAROSCOPIC SKIN ULCER RISK INDEX (CSURI) IN SYSTEMIC SCLEROSIS: RESULTS FROM AN ITALIAN MULTICENTER VALIDATION STUDY 213
Measuring microangiopathy abnormalities in systemic sclerosis patients: the role of capillaroscopy-based scoring models 212
Interstitial lung disease is associated to infections of lower respiratory tract in immunocompromised rheumatoid arthritis patients 211
UNCLASSIFIABLE INTERSTITIAL LUNG DISEASE OR UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE? A CHALLENGING DIFFERENTIAL DIAGNOSIS 211
Nailfold Capillaroscopy Characteristics of Antisynthetase Syndrome and Possible Clinical Associations: Results of a Multicenter International Study 209
RHEUMATOID ARTHRITIS RELATED INTERSTITIAL LUNG DISEASE. RADIOLOGICAL PATTERNS AND CORRELATIONS WITH CLINICAL, SEROLOGICAL AND DEMOGRAPHIC FEATURES OF DISEASE 209
AB0472 PRIMARY SJOGREN SYNDROME ASSOCIATED INTERSTITIAL LUNG DISEASE: FEATURES, TREATMENT AND OUTCOME OF A MONOCENTRIC COHORT 209
Efficacy and safety of mycophenolate mofetil in the treatment of rheumatic disease-related interstitial lung disease: a narrative review 208
The performance of the GAP model in patients with rheumatoid arthritis associated interstitial lung disease 207
Scleroderma Digital Ulcers Complicated by Infection with Fecal Pathogens. 204
AB0624 SAFETY OF RITUXIMAB BIOSIMILAR FOR THE TREATMENT OF CRYOGLOBULINEMIC VASCULITIS 203
Neurologic Complications Associated with Sjögren's Disease: Case Reports and Modern Pathogenic Dilemma 198
Osteomyelitis complicating scleroderma digital ulcers. 197
Procedural pain management in the treatment of scleroderma digital ulcers 197
Chemokine (CXC motif) ligand 9 serum levels in mixed cryoglobulinemia are associated with circulating levels of IFN-γ and TNF-α 194
Factors Predicting Early Failure of Etanercept in Rheumatoid Arthritis: An Analysis From the Gruppo Italiano di Studio sulla Early Arthritis (Italian Group for the Study of Early Arthritis) Registry 193
INTERSTITIAL LUNG DISEASE IS ASSOCIATED TO INFECTIONS OF LOWER RESPIRATORY TRACT IN IMMUNOCOMPROMISED RHEUMATOID ARTHRITIS PATIENTS 193
Nailfold videocapillaroscopy in antisynthetase syndrome 193
PATIENTS WITH MIXED CRYOGLOBULINEMIA AND HCV INFECTION, IN PRESENCE OR ABSENCE OF AUTOIMMUNE THYROIDITIS, HAVE HIGH SERUM LEVELS OF (CXC MOTIF) LIGAND (CXCL)9 AND CXCL11 CHEMOKINES 186
Erratum: Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature (Journal of Thoracic Disease (2019) 11 (1621-1628) DOI: 10.21037/jtd.2019.03.28) 186
Efficacy and safety of rituximab in the treatment of connective tissue disease-related interstitial lung disease 186
Mixed cryoglobulinemia syndrome: where are we going to? 185
Thyroid involvement in hepatitis C - associated mixed cryoglobulinemia 185
Italian consensus recommendations for the management of hepatitis C infection in patients with rheumatoid arthritis 182
Trattamento della fascite eosinofila con D-penicillamina: descrizione di 3 casi. 181
Tocilizumab for the treatment of patients with rheumatoid arthritis and interstitial lung diseases: a case series 181
DIGITAL NECROSIS IN SYSTEMIC SCLEROSIS NOT ONLY A MICROVASCULAR DISEASE: A CASE REPORT 179
Therapeutic Options for the Treatment of Interstitial Lung Disease Related to Connective Tissue Diseases. A Narrative Review 179
PAP-TEST FEATURES IN A COHORT OF SYSTEMIC SCLEROSIS PATIENTS 177
NAILFOLD VIDEOCAPILLAROSCOPY FEATURES OF PATIENTS WITH ANTISYNTHETASE SYNDROME 172
Scleroderma skin ulcers definition, classification and treatment strategies our experience and review of the literature 172
Trattamento con IgIV ad alte dosi in un caso di dermatomiosite con grave disfagia refrattaria alle terapie standard. 171
Predictive Value of DLCO Reduction in Scleroderma Patients Without Cardio-Pulmonary Involvement at Baseline 170
FRI0613 THERAPEUTIC STRATEGIES AND SURVIVAL IN PATIENTS WITH INTERSTITIAL PNEUMONIA WITH AUTOIMMUNE FEATURES 170
SEVERE VITAMIN D DEFICIENCY IN SYSTEMIC SCLEROSIS 169
Pirfenidone for the treatment of interstitial lung disease associated to rheumatoid arthritis: a new scenario is coming? 168
Prise en charge de l'infection par le virus de l'hépatite B chez les patients atteints de polyarthrite rhumatoïde: conférence de consensus italienne [Italian consensus guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis] 167
Totale 31.050
Salva come PNG Salva come JPEG
Categoria #
all - tutte 154.149
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 154.149
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.695 0 0 0 0 0 404 370 550 297 458 306 310
2021/20223.473 193 277 265 268 170 287 182 196 389 316 512 418
2022/20234.459 457 336 271 316 439 532 264 438 536 204 391 275
2023/20244.240 221 274 279 454 574 346 356 548 153 240 343 452
2024/20258.032 334 198 231 585 1.540 1.135 590 418 821 423 794 963
2025/20267.628 800 516 1.011 2.020 3.042 239 0 0 0 0 0 0
Totale 39.324